Minerva Other Operating Expenses from 2010 to 2026
| NERV Stock | USD 3.97 0.07 1.79% |
Other Operating Expenses | First Reported 2012-12-31 | Previous Quarter 3.4 M | Current Value 2.8 M | Quarterly Volatility 6.2 M |
Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Neurosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 34.5 M, Research Development of 23.6 M or EBITDA of 5.7 M, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.
Minerva | Other Operating Expenses | Build AI portfolio with Minerva Stock |
Latest Minerva Neurosciences' Other Operating Expenses Growth Pattern
Below is the plot of the Other Operating Expenses of Minerva Neurosciences over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Minerva Neurosciences. It is also known as Minerva Neurosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Minerva Neurosciences' Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Minerva Neurosciences' overall financial position and show how it may be relating to other accounts over time.
| Other Operating Expenses | 10 Years Trend |
|
Other Operating Expenses |
| Timeline |
Minerva Other Operating Expenses Regression Statistics
| Arithmetic Mean | 29,229,693 | |
| Geometric Mean | 17,060,270 | |
| Coefficient Of Variation | 73.04 | |
| Mean Deviation | 16,368,506 | |
| Median | 26,110,000 | |
| Standard Deviation | 21,348,914 | |
| Sample Variance | 455.8T | |
| Range | 77M | |
| R-Value | 0.40 | |
| Mean Square Error | 410.2T | |
| R-Squared | 0.16 | |
| Significance | 0.12 | |
| Slope | 1,671,349 | |
| Total Sum of Squares | 7292.4T |
Minerva Other Operating Expenses History
About Minerva Neurosciences Financial Statements
Minerva Neurosciences investors use historical fundamental indicators, such as Minerva Neurosciences' Other Operating Expenses, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Operating Expenses | 25.1 M | 34.5 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Minerva Stock Analysis
When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.